350 related articles for article (PubMed ID: 27009453)
1. Stereotactic Body Radiotherapy in the Management of Oligometastatic Disease.
Ahmed KA; Torres-Roca JF
Cancer Control; 2016 Jan; 23(1):21-9. PubMed ID: 27009453
[TBL] [Abstract][Full Text] [Related]
2. Stereotactic body radiation therapy for oligometastases.
Lo SS; Fakiris AJ; Teh BS; Cardenes HR; Henderson MA; Forquer JA; Papiez L; McGarry RC; Wang JZ; Li K; Mayr NA; Timmerman RD
Expert Rev Anticancer Ther; 2009 May; 9(5):621-35. PubMed ID: 19445579
[TBL] [Abstract][Full Text] [Related]
3. The role of stereotactic body radiation therapy (SBRT) in the treatment of oligometastatic disease in the elderly.
Scorsetti M; Clerici E; Navarria P; D'Agostino G; Piergallini L; De Rose F; Ascolese A; Tozzi A; Iftode C; Villa E; Comito T; Franzese C; Mancosu P; Tomatis S; Cozzi L
Br J Radiol; 2015 Sep; 88(1053):20150111. PubMed ID: 26183933
[TBL] [Abstract][Full Text] [Related]
4. Extracranial radiosurgery (stereotactic body radiation therapy) for oligometastases.
Kavanagh BD; McGarry RC; Timmerman RD
Semin Radiat Oncol; 2006 Apr; 16(2):77-84. PubMed ID: 16564443
[TBL] [Abstract][Full Text] [Related]
5. A single-institution study of stereotactic body radiotherapy for patients with unresectable visceral pulmonary or hepatic oligometastases.
Fumagalli I; Bibault JE; Dewas S; Kramar A; Mirabel X; Prevost B; Lacornerie T; Jerraya H; Lartigau E
Radiat Oncol; 2012 Sep; 7():164. PubMed ID: 23014094
[TBL] [Abstract][Full Text] [Related]
6. Stereotactic Body Radiotherapy in the Treatment of Spinal Metastases.
Katsoulakis E; Kumar K; Laufer I; Yamada Y
Semin Radiat Oncol; 2017 Jul; 27(3):209-217. PubMed ID: 28577828
[TBL] [Abstract][Full Text] [Related]
7. Stereotactic radiotherapy in oligoprogressive and oligorecurrent urothelial cancer patients: A retrospective experience.
Francolini G; Desideri I; Detti B; Di Cataldo V; Masi L; Caramia G; Visani L; Terziani F; Muntoni C; Lo Russo M; Loi M; Livi L
Cancer Treat Res Commun; 2019; 19():100124. PubMed ID: 30851645
[TBL] [Abstract][Full Text] [Related]
8. Stereotactic Body Radiotherapy (SBRT) for Spinal Metastases: Who Will Benefit the Most from SBRT?
Park HJ; Kim HJ; Won JH; Lee SC; Chang AR
Technol Cancer Res Treat; 2015 Apr; 14(2):159-67. PubMed ID: 24502552
[TBL] [Abstract][Full Text] [Related]
9. Ablative dose stereotactic body radiation therapy for oligometastatic disease: a prospective single institution study.
Burkon P; Kazda T; Pospisil P; Slavik M; Kominek L; Selingerova I; Blakaj DM; Prochazka T; Vrzal M; Rehak Z; Slampa P
Neoplasma; 2019 Mar; 66(2):315-325. PubMed ID: 30509112
[TBL] [Abstract][Full Text] [Related]
10. Stereotactic body radiation therapy for abdominal oligometastases: a biological and clinical review.
Almaghrabi MY; Supiot S; Paris F; Mahé MA; Rio E
Radiat Oncol; 2012 Aug; 7():126. PubMed ID: 22852764
[TBL] [Abstract][Full Text] [Related]
11. Oligometastatic Disease State Is Associated with Improved Local Control in Patients Undergoing Three or Five Fraction Spine Stereotactic Body Radiotherapy.
Silva SR; Gliniewicz A; Martin B; Prabhu VC; Germanwala AV; Melian E; Jones GA; Solanki AA
World Neurosurg; 2019 Feb; 122():e342-e348. PubMed ID: 30326310
[TBL] [Abstract][Full Text] [Related]
12. Stereotactic body radiotherapy for oligometastatic disease.
Hanna GG; Landau D
Clin Oncol (R Coll Radiol); 2015 May; 27(5):290-7. PubMed ID: 25770653
[TBL] [Abstract][Full Text] [Related]
13. Stereotactic body radiotherapy for oligometastatic lung tumors.
Norihisa Y; Nagata Y; Takayama K; Matsuo Y; Sakamoto T; Sakamoto M; Mizowaki T; Yano S; Hiraoka M
Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):398-403. PubMed ID: 18374506
[TBL] [Abstract][Full Text] [Related]
14. Re-irradiation stereotactic body radiotherapy for spinal metastases: a multi-institutional outcome analysis.
Hashmi A; Guckenberger M; Kersh R; Gerszten PC; Mantel F; Grills IS; Flickinger JC; Shin JH; Fahim DK; Winey B; Oh K; John Cho BC; Létourneau D; Sheehan J; Sahgal A
J Neurosurg Spine; 2016 Nov; 25(5):646-653. PubMed ID: 27341054
[TBL] [Abstract][Full Text] [Related]
15. Stereotactic body radiotherapy for oligometastases.
Tree AC; Khoo VS; Eeles RA; Ahmed M; Dearnaley DP; Hawkins MA; Huddart RA; Nutting CM; Ostler PJ; van As NJ
Lancet Oncol; 2013 Jan; 14(1):e28-37. PubMed ID: 23276369
[TBL] [Abstract][Full Text] [Related]
16. Stereotactic body radiation therapy in multiple organ sites.
Timmerman RD; Kavanagh BD; Cho LC; Papiez L; Xing L
J Clin Oncol; 2007 Mar; 25(8):947-52. PubMed ID: 17350943
[TBL] [Abstract][Full Text] [Related]
17. Role of stereotactic body radiotherapy for oligometastasis from colorectal cancer.
Takeda A; Sanuki N; Kunieda E
World J Gastroenterol; 2014 Apr; 20(15):4220-9. PubMed ID: 24764660
[TBL] [Abstract][Full Text] [Related]
18. Esophageal dose tolerance to hypofractionated stereotactic body radiation therapy: risk factors for late toxicity.
Stephans KL; Djemil T; Diaconu C; Reddy CA; Xia P; Woody NM; Greskovich J; Makkar V; Videtic GM
Int J Radiat Oncol Biol Phys; 2014 Sep; 90(1):197-202. PubMed ID: 25015204
[TBL] [Abstract][Full Text] [Related]
19. A Contemporary Update on the Role of Stereotactic Body Radiation Therapy (SBRT) for Liver Metastases in the Evolving Landscape of Oligometastatic Disease Management.
Robin TP; Raben D; Schefter TE
Semin Radiat Oncol; 2018 Oct; 28(4):288-294. PubMed ID: 30309639
[TBL] [Abstract][Full Text] [Related]
20. [Local ablative radiotherapy of oligometastatic colorectal cancer].
Petersen C; Gauer T
Radiologe; 2017 Feb; 57(2):105-110. PubMed ID: 28054139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
